AMBS does need to answer some of the questions but fib needs to chill out on trial size. AMBS is going after CLIA first. Larger study will be done for FDA launch. 10 patients is not the full trial size.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links